ライフサイエンスコーパス: approved by

1 ining NTRK gene fusions are the most recent targeted agents approved by the US Food and Drug Administration, olaparib for

2 Data were analyzed on new therapeutic agents approved by the US Food and Drug Administration (FDA) between

3 Multiple human-safe sugar substitutes are already approved by the U.S. Food and Drug Administration and are rea

4 This expert review was commissioned and approved by the AGA Institute Clinical Practice Updates Commi

5 This expert commentary was commissioned and approved by the AGA Institute Clinical Practice Updates Commi

6 r (EGFR) tyrosine kinase inhibitors have been developed and approved by Food and Drug Administration for the treatment of

7 nology, hundreds of biotherapeutics have been developed and approved by the US Food and Drug Administration (FDA) for hum

8 This study was retrospectively registered and approved by the Thai Clinical Trial Registry (TCTR) on 2019-1

9 dy was designed as an observational, longitudinal trial and approved by the local ethics committee.

10 titution patterns of benzenoid rings in small molecule APIs approved by the FDA through 2019 and show that only a few sub

11 st factors targeted by 69 compounds (of which, 29 drugs are approved by the US Food and Drug Administration, 12 are in cl

12 e currently tested in clinical trials, and none of them are approved by health agencies.

13 Both treatments are approved by the US Food and Drug Administration (FDA) for r/r

14 rize antisense oligonucleotide drugs that have already been approved by the Food and Drug Administration for targeting mR

15 d of January 2020, no treatment for food allergies had been approved by the US Food and Drug Administration.

16 amine, in conjunction with an oral antidepressant, has been approved by the FDA for treating treatment-resistant major de

17 ake of SSBs.The Health Workers Cohort Study (HWCS) has been approved by the Institutional Review Board of the Mexican Soc

18 is a noninvasive brain stimulation treatment that has been approved by the U.S. Food and Drug Administration for treatme

19 Four PARP inhibitors have been approved by the FDA as cancer therapeutics, yet a precise mec

20 DA Green Book is a list of all drug products that have been approved by the FDA for use in veterinary medicine.

21 Only about two dozen formulations have been approved by the U.S. Food and Drug Administration during the

22 The most common biomarker approved by the FDA (United States Food and Drug Administrati

23 ment of PAH rats with dofetilide, an Kv11.1 channel blocker approved by the US Food and Drug Administration for use in th

24 We developed a high-throughput screen to identify compounds approved by the US Food and Drug Administration that reduce a

25 Paediatric dolutegravir doses approved by stringent regulatory authorities (SRAs) for child

26 impact of this proposal by identifying antimicrobial drugs approved by the FDA from 2007-2016 that would likely have qua

27 In the absence of drugs approved by regulatory agencies, the current standard of care

28 ng hPSC-LOs, we performed a high-throughput screen of drugs approved by the FDA (US Food and Drug Administration) and ide

29 a human epidermal growth factor receptor 2 (HER2) inhibitor approved by the FDA for HER2-positive breast cancer treatment

30 Conversely, the iStent, approved by the Food and Drug Administration in 2012, increas

31 declared blends of olive oil and seed oil is something long approved by the European Union.

32 s effective in treating bacterial pneumonia, but it was not approved by the U.S. Food and Drug Administration owing, in p

33 for the treatment of Huntington's disease(2), was recently approved by the United States' Food and Drug Administration.

34 Romosozumab, approved by the FDA in 2019, is a humanized sclerostin-neutra

35 ics in children given once daily 25 mg film-coated tablets (approved by the SRAs at the time of the study) in part one of

36 Nivolumab, a monoclonal antibody therapeutic approved by the FDA, binds to PD-1 and efficiently blocks its

37 There are 3 therapies approved by the US Food and Drug Administration for managing

38 Adalimumab is the only treatment approved by either the European Medicines Agency or the U.S.

39 Axicabtagene ciloleucel (axi-cel) was approved by the Food and Drug Administration for relapsed agg

40 ers.TRIAL REGISTRATIONPhase I/II protocol (NCT03480152) was approved by the IRB committee of the NIH and the FDA.FUNDINGC

41 Trial registry The study protocol was approved by the Ethics Committee of Qom University of Medical

42 ow that has been successful since (177)Lu DOTATATE PRRT was approved by the U.S. Food and Drug Administration.

43 Our research was approved by the McGill institutional review board (A04-M47-12

44 The study was approved by the institutional review board and is Health Insu

45 Amiodarone is an anti-arrhythmic drug that was approved by the US Food and Drug Administration (FDA) in 1985

46 vial (pertuzumab, trastuzumab, and hyaluronidase-zzxf) was approved by the US Food and Drug Administration (FDA) on June

47 RATIONPhase II protocols (NCT01498484 and NCT00002663) were approved by the Institutional Review Board at Memorial Sloan

48 Between 2007 and 2020, 33 biosimilars for oncology were approved by the European Medicines Agency (EMA), 16 by the US

49 drugs with initial indications for adult cancers that were approved by the US Food and Drug Administration between Jan 1

50 oated tablet doses of 25 mg or 35 mg once daily, which were approved by the SRAs for the children's weight band; then swi